Edgewood Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Edgewood Management's LLY Position: Q2 2026 in Review
Edgewood Management reduced its Eli Lilly (LLY) stake by 44% in Q2 2026, selling an estimated $311M and leaving 388,627 shares worth $466M. The position accounts for 4.81% of the portfolio, ranked #9.
Edgewood Management first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. The position peaked at $2.06B in Q2 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Edgewood Management held 388,627 shares of Eli Lilly worth $466M as of Q2 2026.
- Edgewood Management sold 304,830 Eli Lilly shares in Q2 2026, an estimated $311M.
- Eli Lilly made up 4.81% of Edgewood Management's portfolio in Q2 2026, its #9 holding.
- Edgewood Management first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
- Edgewood Management's Eli Lilly position peaked at $2.06B in Q2 2024.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Edgewood Management's 13F filing for Q2 2026, filed 13 Aug 2026.